1
This commit is contained in:
@@ -51,7 +51,7 @@ page=57,%号
|
||||
\Abbreviations{COPD, chronic obstructive pulmonary disease; CS, cigarette smoke; ROS, reactive oxygen species; ECM, extracellular matrix; EGFR, epidermal growth factor receptor; NF-κB, nuclear factor kappa-B; TNF-α, tumor necrosis factor-alpha; TGF-β, transforming growth factor-β; IL-6, interleukin-6; IL-1β, interleukin-1 beta; MMP9, matrix metalloproteinase 9; HDAC2, histone deacetylase-2; PI3K, phosphoinositide-3- kinase; Nrf2, nuclear factor erythroid 2-related factor 2; CXCL, C-X-C motif chemokine ligand; NE, neutrophil elastase; MAPK, mitogen-activated protein kinase; EGF, epidermal growth factor; LPS, lipopolysaccharide; TLR4, toll-like receptor 4; JNK, c-Jun N-terminal kinase; SOD, superoxide dismutase; GSH, glutathione; GSH-Px, glutathione peroxidase; HO-1, haem oxygenase 1; MDA, malondialdehyde; SIRT1, silent information regulator 1; NAD+, nicotinamide adenine dinucleotide; GPX4, glutathione peroxidase 4; NADPH, nicotinamide adenine dinucleotide phosphate; GR, glucocorticoid receptor; CSE, cigarette smoke extract; IκB, inhibitor kappa B; HBECs, human bronchial epithelial cells; TLRs, toll-like receptors; IRAK, interleukin-1 receptor-associated kinase; PKC, protein kinase C; NOX4, NADPH oxidase 4; TIMP, tissue inhibitors of metalloproteinase; EMT, epithelial-mesenchymal transition; α-SMA, alpha smooth muscle actin; ERK, extracellular regulated protein kinases; AKT, protein kinase B.}
|
||||
\Citation{Shi PL, Zhang GX, Wang PY, et al. Natural flavonoids for the treatment of chronic obstructive pulmonary disease: An overview. \textit{Tradit Med Res}. 2025;10(9):57. doi:10.53388/TMR20241121001}
|
||||
\received{22 November 2024}
|
||||
\revised{28 November 2024}
|
||||
%\revised{28 November 2024}
|
||||
\accepted{27 February 2025}
|
||||
\Availableonline{3 March 2025}
|
||||
\EditorialAdvisoryBoard{lixiang}
|
||||
|
||||
Reference in New Issue
Block a user